Back to First Trust Advisors LP First Trust Advisors LP

CORTCORT

Showing 8 of 30 quarters

Position history for First Trust Advisors LPFirst Trust Advisors LP's holdings in Corcept Therapeutics Incorporated

Yes. First Trust Advisors holds 1,829,545 shares of CORT (Corcept Therapeutics), worth $159.1M, as of its Q2 2026 13F filing. It reduced the position by 343,831 shares (-15.8%) from Q1 2026. First Trust Advisors has held CORT since Q1 2019, across 30 quarterly 13F filings. CORT is 0.1% of First Trust Advisors' reported 13F portfolio.

Current Value

$159.1M

Current Shares

1.8M

Total Value Change

+$98.1M

Total Shares Change

+511,408

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.8M
-15.8%
$159.1M0.1%$86.95
0
2026-Q1
Increased
2.2M
+213.5%
$87.6M0.1%$40.31
48
2025-Q4
Decreased
693,317
-3.7%
$24.1M0.0%$34.80
0
2025-Q3
Increased
720,224
+34.1%
$59.9M0.0%$83.11
38
2025-Q2
Decreased
537,186
-41.9%
$39.4M0.0%$73.40
0
2025-Q1
Decreased
924,317
-13.1%
$105.6M0.1%$114.22
0
2024-Q4
Decreased
1.1M
-19.3%
$53.6M0.0%$50.39
0
2024-Q3
Decreased
1.3M
-13.4%
$61M0.1%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used